[Prolongation of the effect of immunostimulators as means of increasing resistance to causative agents of infection].
Sviridov. L P LP; Stepanov. A V AV
Key Findings
- Aluminium hydrate binding increased the biological activity of thymalin and similar immunostimulators
- The sorbed compounds provided a longer‑lasting boost in resistance to gas gangrene and typhoid fever in experimental models
- The stronger anti‑infection effect was linked to heightened stimulation of nonspecific immune factors
Practical Outcomes
- While the idea of aluminium‑bound immune peptides sounds promising for enhancing resistance to infections, the lack of human data, dosing guidelines, and safety information means it isn’t ready for DIY use. Enthusiasts should wait for further studies before incorporating such formulations into their protocols.
Summary
The study found that attaching immune‑boosting peptides like thymalin to a form of aluminium (aluminium hydrate) makes them work stronger and last longer, helping animals resist serious infections such as gas gangrene and typhoid fever. However, the research is early‑stage, doesn’t give clear dosing instructions, and the safety of aluminium‑bound compounds isn’t well established for people.
Abstract
Possible prolongation of the biological effect of some available immunostimulators such as prodigiozan, salmozan, polyribonate and thymalin by their sorption on aluminium hydrate was studied. It was shown that in comparison to the native immunostimulators the sorbed ones had a more pronounced biological action and provided a more prolonged increase in the host resistance to the causative agents of gas gangrene and typhoid fever. Using prodigiozan as an example it was demonstrated that the observed increase in the anti-infective activity of the sorbed drugs was associated with more intensive stimulation of some immunological factors involved in regulation of host nonspecific resistance. The results of the study are likely to indicate that it was experiment to further investigate the drugs to reveal their efficacy in other infection models and to optimize the schemes of their use.
Study Information
pubmed
1990